Skip to content

DarwinHealth Publication Reports Step-by-Step Protocol for its Tumor Checkpoint-Based, Compound-to-Clinic (C2C) Cancer Drug Discovery Pipeline: Elucidates a Patient-to-Model-to-Patient (PMP) Roadmap for Precision- and Mechanism-Based Identification and Clinical Validation of Novel, Investigational and FDA-Approved Therapeutic Agents Targeting Tumor Regulatory Architecture

By asianet

DarwinHealth, Inc., (www.DarwinHealth.com) a New York-based biotechnology and cancer drug discovery company announces the September 9, 2022 online publication in Current Protocols (Wiley Science) of their proprietary cancer drug discovery and validation pipeline, “A Patient-to-Model-to-Patient (PMP) cancer drug and biomarker discovery protocol for identifying and validating therapeutic agents targeting tumor regulatory architecture.” Logo – https://mma.prnewswire.com/media/966600/DarwinHealth_Logo.jpg … Continued

EpiVax Secures Additional Funding from FDA for Immunogenicity Risk Assessment for Biosimilar Products

By asianet

EpiVax, Inc. (“EpiVax”) is pleased to announce the award of a two-year, $2 million grant from the FDA’s Office of Center for Drug Evaluation and Research (CDER) to validate a method for immunogenicity risk assessment of host cell proteins (HCP) for improving biosimilar product development and assessing product interchangeability (# U01FD007760). The research will commence … Continued

MASSIMO CALAFIORE APPOINTED AS NEW LIMACORPORATE CEO

By asianet

LimaCorporate, a leading global orthopedic manufacturer focused on digital innovation and patient-tailored devices, today announces that Massimo Calafiore has been appointed by the Board of Directors as the new Chief Executive Officer of the company. Massimo’s appointment follows a thorough selection process that considered both internal and external candidates. Emmanuel Bonhomme, who has led the organization … Continued

FDI WORLD DENTAL FEDERATION LAUNCHES TOOLKIT ON HOW TO MAKE DENTISTRY MORE SUSTAINABLE

By asianet

Dental practices can use the tools as a guide to make their work more environmentally sustainable and by tracking progress they can achieve recognition awards for their efforts. FDI World Dental Federation (FDI) today launched a Toolkit for Sustainable Dentistry[https://www.sustainability-platform.fdiworlddental.org/], to help dental practices understand what actions they can take to ensure their work is … Continued

First patient enrolled in Erectile Dysfunction prospective randomized study with SELUTION SLR

By asianet

An 82-year-old Taiwanese man has become the first patient to be enrolled in the initial Erectile Dysfunction (ED) randomized clinical trial (RCT) involving SELUTION SLR™, MedAlliance’s novel sirolimus-eluting balloon. The PERFECT-SELUTION FIM (PElvic Revascularization For EreCTile dysfuction-SELUTION First-In-Man) study involves a total of 54 patients suffering from distal internal pudendal-penile artery stenotic disease and ED. … Continued

ESMO 2022 – Great oaks grow from small acorns: oncology is committed to doing its part for sustainability

By asianet

At ESMO 2022, 9-13 September, Paris, France, the premier cancer congress in Europe, which has gathered 28k participants from 167 countries, many discussions will be around sustainability, prevention and novel approaches which could soon become a reality in the clinic. – Late-breaking results elucidate the link between air pollution and lung cancer in people who … Continued

ONE DRUG FOR ONE BUG: DEBIOPHARM TO DISCUSS THE POTENTIAL OF PATHOGEN-SPECIFIC ANTIBIOTICS AT THE 2022 WORLD AMR CONGRESS

By asianet

– International health authorities, such as the WHO and the CDC are warning of the emerging danger of bacterial infections resistant to current antibiotics – The 2022 World Anti-Microbial Resistance (AMR) Congress in the greater Washington D.C. area is serving as a forum to openly address the threat of AMR – Debiopharm will join the … Continued

Non-invasive skin immune biomarker test helps predict development of eczema in babies, new study presented at the EADV Congress finds

By asianet

Researchers have identified an immune biomarker in newborns that can predict the subsequent onset and severity of paediatric atopic eczema, a new study presented at the 31st European Academy of Dermatology and Venereology (EADV) Congress has shown. The Barrier dysfunction in Atopic newBorns (BABY) study analysed a cohort of 450 babies (300 term and 150 … Continued

Hovione expands drug product offering with a new manufacturing line dedicated to Continuous Tableting

By asianet

Hovione, the leader in spray drying and particle engineering, announced today that it has expanded its continuous manufacturing offering and services. A new state-of-the-art continuous manufacturing facility is now coming online at the Loures site in Portugal. In addition, to support Hovione’s commitment to providing access and services for continuous tableting, Hovione has further strengthened … Continued

PharmaLex Strengthens Global Reach and Local Support with Offices in China

By asianet

PharmaLex Group, a leading provider of specialized services for the pharma, biotech and medtech industries worldwide, has announced the opening of a new branch in Beijing, China, giving global clients access to a team of regulatory experts in the region. As of September 2022, the newly established PharmaLex Beijing team, which includes personnel joining from … Continued